SCHEMBL12038288

SCHEMBL12038288

CC(=O)Oc1cc2oc(=O)c(C(=O)ON3C(=O)CCC3=O)cc2cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ GLA P06280 3/20 0.49
▸ GAA P10253 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ MAPT P10636 2/20 0.49
▸ CASP1 P29466 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CASP7 P55210 1/20 0.49
▸ GFER P55789 1/20 0.44
▸ F2 P00734 1/20 0.42
▸ CA12 O43570 3/20 0.40
▸ CA9 Q16790 3/20 0.40
▸ MAOB P27338 1/20 0.39
▸ GAPDH P04406 1/20 0.39
▸ HPGD P15428 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14039317 0.93 KMT2A (0.45) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038303 0.88 MAOB (0.40) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038321 0.86 GAPDH (0.39) KDM4EKMT2AGLAGAAMEN1
SCHEMBL13494166 0.85 GPR35 (0.41) KDM4EKMT2AMEN1ALDH1A1HSD17B10
SCHEMBL17942948 0.81 RAB9A (0.50) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038319 0.78 KDM4E (0.54) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038323 0.78 MAOB (0.38) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038427 0.77 KDM4E (0.39) KDM4EKMT2AGLAGAAMEN1
SCHEMBL12038347 0.76 GLA (0.38) KDM4EKMT2AGLAGAAMEN1
SCHEMBL31114267 0.75 GPR35 (0.44) KDM4EKMT2AMEN1ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11175204-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2021-11-16 — — US disclosed
US-9400273-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2016-07-26 — — US disclosed
US-9400273-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2016-07-26 — — US disclosed
US-8318953-B2 Reactive coumarin derivatives and their use in cellular analyses AAT BIOQUEST, INC. (US) 2012-11-27 — — US disclosed
US-8318953-B2 Reactive coumarin derivatives and their use in cellular analyses AAT BIOQUEST, INC. (US) 2012-11-27 — — US disclosed
US-20110318772-A1 REACTIVE COUMARIN DERIVATIVES AND THEIR USE IN CELLULAR ANALYSES AAT BIOQUEST, INC. (US) 2011-12-29 — — US disclosed
US-20110318772-A1 REACTIVE COUMARIN DERIVATIVES AND THEIR USE IN CELLULAR ANALYSES AAT BIOQUEST, INC. (US) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110318772-A1 REACTIVE COUMARIN DERIVATIVES AND THEIR USE IN CELLULAR ANALYSES CYP3A7, XPO7, HCCS KDM4E 4529/4885KMT2A 4772/4885GLA 649/4885
US-11175204-B1 7-hydroxycoumarin-based cell-tracking reagents MKI67, DCX, CDK7 KDM4E 2525/4885KMT2A 2386/4885GLA 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback